𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Generic versus branded pharmacotherapy in Parkinson’s disease: Does it matter? A review

✍ Scribed by Criscely L. Go; Raymond L. Rosales; Peter Schmidt; Kelly E. Lyons; Rajesh Pahwa; Michael S. Okun


Book ID
116820935
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
150 KB
Volume
17
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Does levodopa therapy delay death in Par
✍ Dr. C. E. Clarke 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

Studies examining the mortality from Parkinson's disease have been reviewed to assess the impact of levodopa therapy. These include national mortality data taken from death certificate returns, cohort studies comparing the deaths observed in a group of patients with those expected from population st

Does age make a difference in caregiver
✍ Julie H. Carter; Karen S. Lyons; Barbara J. Stewart; Patricia G. Archbold; Rebec 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract Family care research has identified negative outcomes of providing care to a spouse with Parkinson's disease (PD), such as declining physical and mental health. Research has also identified protective variables that decrease negative outcomes such as high mutuality and rewards of meanin

Neural Transplantation in Parkinson's Di
✍ O. Pogarell; W. H. Oertel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

The transplantation of fetal mesencephalic dopaminergic tissue into the striatum of parkinsonian (PD) patients is an experimental therapeutic approach. The target population for this treatment are advanced, predominantly akinetic-rigid patients with therapy-associated complications, and not tremor-d